John B. Henneman, III
Board Member
Anika Therapeutics, Inc. (ANIK)Chairman
Anika Therapeutics, Inc. (ANIK)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John B. Henneman, III
John B. Henneman, III is recorded as Board Member and Chairman at Anika Therapeutics, Inc. (ANIK). Anika Therapeutics, Inc. reported in an 8-K filed June 23, 2026 that John B. Henneman, III was appointed Class III director, effective June 18, 2026. Anika Therapeutics, Inc. reported in an 8-K filed February 26, 2024 that John B. Henneman, III was appointed Chair of the Board, effective February 24, 2024.
“As a result of this vote, Mr. Fischetti, Mr. Henneman and Mr. Griffin were elected as Class III directors to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier resignation or removal.”
“John B. Henneman, III, an independent director of the Company's Board since 2020, has been appointed Chair of the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-18–present
-
Current
2024-02-24–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Anika Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Cheryl Blanchard CEO, Board Member
- Stephen (Steve) Griffin CEO, Board Member
- Stephen D. Griffin CEO, CFO, Board Member
- Steve Griffin CEO, Board Member
- Cheryl R. Blanchard Chairman, Board Member
- Jeffery S. Thompson Chairman
- Michael Levitz CFO
- Stephen Griffin CFO
- Anne Nunes COO
- David B. Colleran General Counsel
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.